Tatsuo Kimura

Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort

Seiji Yano, Tadaaki Yamada, Shinji Takeuchi et al. · Journal of Thoracic Oncology · 2011 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L

Fumihiko Hirai, Takeharu Yamanaka, Kenichi Taguchi et al. · Annals of Oncology · 2014 · 130 citations · Full text

Medicine, Oncology, Pharmacology +5

Grafting neural stem cells improved the impaired spatial recognition in ischemic rats

Hiroki Toda, Jun Takahashi, Noboru Iwakami et al. · Neuroscience Letters · 2001 · 103 citations

Medicine, Neurobiology, Neuroscience +15

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

Naruo Yoshimura, Shinzoh Kudoh, Tatsuo Kimura et al. · Lung Cancer · 2005 · 82 citations

Medicine, Oncology, Pharmacology +10

Phase III Study Comparing Amrubicin Plus Cisplatin With Irinotecan Plus Cisplatin in the Treatment of Extensive-Disease Small-Cell Lung Cancer: JCOG 0509

Miyako Satouchi, Yoshikazu Kotani, Taro Shibata et al. · Journal of Clinical Oncology · 2014 · 80 citations

Medicine, Oncology, Pharmacology +13